Navigation Links
Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award

Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award -- NEUCHATEL, Switzerland, October 4, 2010 /PRNewswire-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Software, Publishing & Information Services, Medical Equipment, Medical Pharmaceuticals, Chemical, Networks, Awards Click to view news release full screen  

Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award


NEUCHATEL, Switzerland, October 4, 2010 /PRNewswire-FirstCall/ -- Elsevier Properties SA today congratulated its Research and Development Director, Professor Dr. Alexander (Sandy) Lawson, for receiving the 2011 Herman Skolnik Award. Presented by the American Chemical Society (ACS) Division of Chemical Information (CINF), the award recognizes outstanding contributions to and achievements in the theory and practice of chemical information science and related disciplines. The prize consists of a $3,000 honorarium and a plaque, which Sandy will receive following a symposium scheduled for the ACS Fall National Meeting in Denver, Aug. 28-Sept. 1, 2011, during the International Year of Chemistry. Sandy will also be one of the symposium presenters.

Phil McHale, D.Phil., Chair of the CINF Awards Committee, said of the award, "Sandy Lawson has contributed so much to cheminformatics; the tools and databases with which he has been (and is still) involved are in daily use by thousands of scientists. Sandy is widely respected throughout the cheminformatics community as a thought leader and a colleague, and he is a most deserving recipient of this award."

Sandy spearheads the innovation and development efforts in the area of cheminformatics at Elsevier Properties SA. He works closely with the Reaxys(R) database and software development teams based at Elsevier Information Systems in Frankfurt; and is instrumental in developing new analysis techniques and functionality for Reaxys (R).

Phil Mestecky, Managing Director Elsevier Properties SA, said, "Sandy's passion for chemistry is clear from the first moment you meet him. This passion combined with his sharp intelligence and insight in to the mind of a research chemist have helped him guide and develop some truly outstanding software and database tools including both the CrossFire suite and Reaxys. However, if you asked Sandy he'll tell you his greatest pieces of work are the last one and the next one. I have been privileged to work with Sandy over the last four years initially at Elsevier Information Systems in Frankfurt and latterly at Elsevier Properties SA in Switzerland. The Skolnik Award is a great honor for Sandy, one he truly deserves, and I know that it will inspire him to even greater endeavors."

About Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks including Reaxys(R), PharmaPendium(TM), SciVal(TM) and The Lancet(R) are owned and protected by Elsevier Properties SA and used under license. For additional information see

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet ( and Cell (, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (, SciVerse Scopus (, Reaxys (, MD Consult ( and Nursing Consult (, which enhance the productivity of science and health professionals, and the SciVal suite ( and MEDai's Pinpoint Review (, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Harald Boersma Senior Manager, Corporate Relations, Elsevier +31-20-485-27-36

SOURCE Elsevier Properties SA and Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
2. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
3. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
4. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
5. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
6. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
7. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
8. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
9. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
10. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
11. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
Breaking Medicine News(10 mins):